Support PenkeStemPoint Capital LP
Portfolio
Holdings
| Symbol | Name | Country | Sector | Industry | Most recent quarter | % of Total Shares | % of Total Assets | Shares | Book Value | Market Price Value | Fundamental Score | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ACHL.NASDAQ | Achilles Therapeutics PLC ADR | USA | Healthcare | Biotechnology | 2024-09-30 | 3.245 | 0.458 | 1.3m | $3.4m | $1.9m |
| |||||||||||||
| ACIU.NASDAQ | AC Immune Ltd | USA | Healthcare | Biotechnology | 2024-09-30 | 0.44 | 0.58 | 434.5k | $634.9k | $1m |
| |||||||||||||
| AGLE.NASDAQ | AGLE.NASDAQ | - | - | - | - | 1.048 | 2.175 | 378.7k | - | - | ||||||||||||||
| APLT.NASDAQ | Applied Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.336 | 3.956 | 1.5m | $79.2k | $811.4k |
| |||||||||||||
| ARQT.NASDAQ | Arcutis Biotherapeutics Inc | USA | Healthcare | Biotechnology | 2024-12-31 | 1.519 | 4.951 | 1.7m | $2.3m | $26.9m |
| |||||||||||||
| ATXS.NASDAQ | Astria Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.561 | 1.644 | 856.9k | $5.1m | $6.1m |
| |||||||||||||
| AUTL.NASDAQ | Autolus Therapeutics Ltd | USA | Healthcare | Biotechnology | 2024-09-30 | 0.983 | 2.844 | 2.6m | $4.6m | $5.1m |
| |||||||||||||
| AVDL.NASDAQ | Avadel Pharmaceuticals PLC | USA | Healthcare | Drug Manufacturers - Specialty & Generic | 2024-09-30 | 0.233 | 0.999 | 223.6k | $173.3k | $1.7m |
| |||||||||||||
| BDTX.NASDAQ | Black Diamond Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.193 | 0.923 | 674.1k | $1.1m | $1.2m |
| |||||||||||||
| CABA.NASDAQ | Cabaletta Bio Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 2.616 | 1.807 | 1.2m | $4.5m | $2.4m |
| |||||||||||||
| CAPR.NASDAQ | Capricor Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.206 | 0.426 | 93.6k | $140.5k | $1.2m |
| |||||||||||||
| CDTX.NASDAQ | Cidara Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.435 | 0.32 | 47.6k | $503.2k | $1m |
| |||||||||||||
| EFTR.NASDAQ | Effector Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 2.823 | 0.505 | 132.7k | -$163.6k | $132.79 |
| |||||||||||||
| FULC.NASDAQ | Fulcrum Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-12-31 | 1.116 | 1.269 | 696.4k | $3.1m | $2.1m |
| |||||||||||||
| IMTX.NASDAQ | Immatics NV | USA | Healthcare | Biotechnology | 2024-09-30 | 0.991 | 2.866 | 1m | $3.5m | $4.5m |
| |||||||||||||
| IMVT.NASDAQ | Immunovant Inc | USA | Healthcare | Biotechnology | 2024-12-31 | 0.659 | 6.916 | 1.1m | $2.3m | $21.9m |
| |||||||||||||
| JSPR.NASDAQ | Jasper Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-12-31 | 0.857 | 1.003 | 129.2k | $516.84 | $696.4k |
| |||||||||||||
| KALV.NASDAQ | Kalvista Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-10-31 | 2.009 | 2.099 | 992.8k | $2.6m | $12.3m |
| |||||||||||||
| LRMR.NASDAQ | Larimar Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.104 | 1.501 | 704.3k | $2.1m | $1.8m |
| |||||||||||||
| PYXS.NASDAQ | Pyxis Oncology Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.43 | 0.934 | 850.2k | $2.1m | $943.7k |
| |||||||||||||
| ROIV.NASDAQ | Roivant Sciences Ltd | USA | Healthcare | Biotechnology | 2024-12-31 | 0.481 | 9.901 | 3.5m | $27.2m | $37.6m |
| |||||||||||||
| SCPH.NASDAQ | Scpharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.573 | 0.949 | 567.2k | $348.2k | $1.7m |
| |||||||||||||
| SNDX.NASDAQ | Syndax Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 3.365 | 9.48 | 2.8m | $12.3m | $37.3m |
| |||||||||||||
| SRZN.NASDAQ | Surrozen Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 10.79 | 1.256 | 350.5k | $611.3k | $4.1m |
| |||||||||||||
| STTK.NASDAQ | Shattuck Labs Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.311 | 0.281 | 147.7k | $280.7k | $192k |
| |||||||||||||
| TARA.NASDAQ | Protara Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.956 | 0.438 | 332.3k | $782.1k | $1.3m |
| |||||||||||||
| TCRX.NASDAQ | Tscan Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-12-31 | 1.524 | 1.284 | 860.9k | $1.7m | $1.5m |
| |||||||||||||
| TSHA.NASDAQ | Taysha Gene Therapies Inc | USA | Healthcare | Biotechnology | 2024-12-31 | 0.582 | 0.825 | 1m | $379.6k | $1.8m |
| |||||||||||||
| VIGL.NASDAQ | Vigil Neuroscience Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.819 | 0.757 | 743.7k | $1.6m | $1.7m |
| |||||||||||||
| VTGN.NASDAQ | VistaGen Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-12-31 | 8.223 | 1.485 | 2.3m | $6.1m | $6.3m |
|
Trades
Buys
Report date: 2024-12-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| CDTX.NASDAQ | 47.6k | - | 774.1k | 10-27 | $23.00 | 126.8% |
| KALV.NASDAQ | 992.8k | - | 10.2m | 8-13 | $12.45 | 56.2% |
Report date: 2024-09-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| CAPR.NASDAQ | 93.6k | - | 463.1k | 4-16 | $13.07 | 271.3% |
Report date: 2024-06-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| BDTX.NASDAQ | 674.1k | - | 3.6m | 4-8 | $1.79 | -59.4% |
| SRZN.NASDAQ | 143.5k | - | 1.4m | 8-15 | $11.96 | 46.9% |
| TCRX.NASDAQ | 845k | - | 6.6m | 6-10 | $1.80 | -67.9% |
| VIGL.NASDAQ | 744.4k | - | 2.5m | 2-6 | $2.35 | -4.9% |
Report date: 2024-03-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ACHL.NASDAQ | 1.3m | - | 1.4m | 1-2 | $1.39 | 73.8% |
| AVDL.NASDAQ | 223.6k | - | 3.3m | 12-17 | $7.96 | -32.7% |
| EFTR.NASDAQ | 132.7k | - | 1.3m | 0-18 | $0.00 | -99.7% |
| JSPR.NASDAQ | 129.2k | - | 2.2m | 1-31 | $5.39 | 740.9% |
| PYXS.NASDAQ | 1.7m | - | 7.5m | 2-7 | $1.11 | -38.0% |
| TARA.NASDAQ | 168.4k | - | 543.5k | 2-5 | $4.10 | 127.8% |
| TSHA.NASDAQ | 1m | - | 2.2m | 1-4 | $1.73 | 25.4% |
Report date: 2023-12-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ACIU.NASDAQ | 434.5k | - | 1.3m | 2-5 | $2.32 | 5.5% |
| AGLE.NASDAQ | 378.7k | - | 0.00 | 0-0 | - | - |
| APLT.NASDAQ | 907.1k | - | 2.2m | 2-3 | $0.52 | -70.8% |
| ARQT.NASDAQ | 2.5m | - | 7m | 2-5 | $15.16 | 761.4% |
| ATXS.NASDAQ | 856.9k | - | 4.7m | 4-8 | $7.14 | 67.6% |
| CABA.NASDAQ | 450.7k | - | 7.5m | 10-24 | $1.91 | -80.0% |
| IMTX.NASDAQ | 1m | - | 9.3m | 7-12 | $4.45 | -37.8% |
| KALV.NASDAQ | 423.1k | - | 3.8m | 7-13 | $12.45 | 72.7% |
| LRMR.NASDAQ | 783.1k | - | 2.6m | 2-5 | $2.65 | 21.6% |
| SCPH.NASDAQ | 567.2k | - | 3.2m | 5-7 | $3.08 | -33.5% |
| SNDX.NASDAQ | 1m | - | 16.8m | 11-22 | $13.00 | 15.9% |
| STTK.NASDAQ | 147.7k | - | 403k | 1-8 | $1.30 | -2.3% |
| VTGN.NASDAQ | 1.7m | - | 6.7m | 2-5 | $2.72 | 11.0% |
Adds
Report date: 2024-12-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| IMVT.NASDAQ | 447.5k | 66.7 | 12.6m | 24-32 | $19.61 | -17.9% |
| SNDX.NASDAQ | 1.1m | 65.9 | 19.5m | 12-23 | $13.00 | 4.8% |
| SRZN.NASDAQ | 167.6k | 91.7 | 1.7m | 8-16 | $11.96 | 47.7% |
| VTGN.NASDAQ | 481.7k | 26.1 | 1.3m | 2-3 | $2.72 | 22.5% |
Report date: 2024-09-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ARQT.NASDAQ | 812.9k | 84.2 | 8m | 8-11 | $15.16 | 92.9% |
| CABA.NASDAQ | 100.3k | 8.5 | 580.5k | 3-9 | $1.91 | -45.0% |
| SNDX.NASDAQ | 319k | 22.6 | 6.5m | 17-25 | $13.00 | -25.0% |
| SRZN.NASDAQ | 39.4k | 27.5 | 348k | 6-12 | $11.96 | 99.3% |
| TCRX.NASDAQ | 15.8k | 1.9 | 95.8k | 5-8 | $1.80 | -63.3% |
Report date: 2024-06-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| APLT.NASDAQ | 194.3k | 9.6 | 919.4k | 4-7 | $0.52 | -86.8% |
| CABA.NASDAQ | 174.1k | 17.4 | 2.1m | 7-19 | $1.91 | -72.3% |
| FULC.NASDAQ | 289.3k | 71.1 | 2.1m | 6-10 | $3.03 | -46.7% |
| IMVT.NASDAQ | 384.6k | 61.3 | 10.9m | 25-32 | $19.61 | -20.5% |
| SNDX.NASDAQ | 311.1k | 28.3 | 6.5m | 19-24 | $13.00 | -30.3% |
| TARA.NASDAQ | 815.6k | 484.2 | 2.3m | 2-5 | $4.10 | 118.1% |
Report date: 2024-03-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| APLT.NASDAQ | 1.1m | 122.3 | 4.9m | 2-9 | $0.52 | -71.8% |
| AUTL.NASDAQ | 2.5m | 557.0 | 15.6m | 5-7 | $1.98 | -62.6% |
| CABA.NASDAQ | 553.2k | 122.7 | 11.8m | 16-26 | $1.91 | -88.3% |
| KALV.NASDAQ | 737.8k | 174.4 | 9.8m | 11-17 | $12.45 | 16.4% |
| ROIV.NASDAQ | 1.3m | 63.8 | 14.9m | 10-12 | $10.60 | 9.4% |
| SNDX.NASDAQ | 6.4k | 0.6 | 144.8k | 20-25 | $13.00 | -33.6% |
| VTGN.NASDAQ | 58.4k | 3.3 | 280.7k | 4-6 | $2.72 | -30.5% |
Reduces
Report date: 2024-12-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| TARA.NASDAQ | -610.4k | -64.7 | -1.9m | 2-10 | $4.10 | 157.1% |
Report date: 2024-09-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| APLT.NASDAQ | -656.7k | -29.7 | -3.8m | 4-9 | $0.52 | -87.8% |
| AUTL.NASDAQ | -46.1k | -1.7 | -183.9k | 3-5 | $1.98 | -39.8% |
| PYXS.NASDAQ | -352.4k | -29.3 | -1.2m | 3-4 | $1.11 | -60.5% |
| TARA.NASDAQ | -41.2k | -4.2 | -84.7k | 2-3 | $4.10 | 144.0% |
| VIGL.NASDAQ | -693.00 | -0.1 | -2.5k | 3-5 | $2.35 | -18.4% |
| VTGN.NASDAQ | -1.7k | -0.1 | -6.1k | 3-4 | $2.72 | -8.1% |
Report date: 2024-06-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| AUTL.NASDAQ | -302.9k | -10.2 | -1.3m | 3-6 | $1.98 | -36.6% |
| KALV.NASDAQ | -424.2k | -36.5 | -4.9m | 10-13 | $12.45 | 23.2% |
| LRMR.NASDAQ | -36.5k | -4.9 | -279.7k | 6-10 | $2.65 | -55.2% |
| PYXS.NASDAQ | -591.5k | -33.0 | -2.4m | 3-6 | $1.11 | -62.4% |
Report date: 2024-03-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ARQT.NASDAQ | -388.6k | -15.0 | -2.9m | 3-12 | $15.16 | 393.8% |
| LRMR.NASDAQ | -42.2k | -5.4 | -329.5k | 4-14 | $2.65 | -35.2% |
Comments
How you think about this?